Added to YB: 2024-04-22
Pitch date: 2024-04-19
PIRS [bullish]
Pieris Pharmaceuticals, Inc.
+16.68%
current return
Author Info
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Pieris Pharmaceuticals, Inc., a biotechnology company, discovers and develops biotechnological applications.
Market Cap
$22.3M
Pitch Price
$11.66
Price Target
N/A
Dividend
N/A
EV/EBITDA
-0.16
P/E
-1.34
EV/Sales
2.17
Sector
Biotechnology
Category
special_situation
Show full summary:
NoName Portfolio Holding: Pieris Pharmaceuticals, Inc.
PIRS: Stopping R&D funding, seeking strategic alternatives after contacting 500 cos. Potential $75M milestones in near-term + future royalties. Cutting costs extends cash to 2027. Considering accelerating distributions via milestone/royalty monetization deals. Stock -90% YTD. Author views as speculation, mulling buying more on further dip for the potential upside.
Read full article (1 min)